Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly

Qinglian Hu; Wen Li; Xiu-Rong Hu; Qida Hu; Jie Shen; Xuejun Jin; Jun Zhou; Guping Tang; Paul Kim Ho Chu

doi:10.1016/j.biomaterials.2012.05.060

Related publications

Article2011

Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer

Ding‐Ding Guo, Seongho Hong, Hu‐Lin Jiang, Jihye Kim, Arash Minai‐Tehrani, Ji‐Eun Kim, Ji‐Young Shin, Tao Jiang, You-Kyoung Kim, Yun‐Jaie Choi, Chong‐Su Cho, Myung‐Haing Cho

Article2018

Minimalistic supramolecular proteoglycan mimics by co-assembly of aromatic peptide and carbohydrate amphiphiles

Alexandra Brito, Yousef M. Abul‐Haija, Diana Soares da Costa, Ramón Novoa-Carballal, Rui L Reis, Rein V. Ulijn, Ricardo A. Pires, Iva Pashkuleva

Article2003

37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

Gerasimos Aravantinos, G. Fountzlias, P. Kosmidis, Meletios A Dimopoulos, Stathopoulos Gp, N. Pavildis, Dimitrios Bafaloukos, S. Rigatos, S. Karpathios, D. Skarlos

Article1997

Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer

Meletios A Dimopoulos, Christos Papadimitriou, C. Gennatas, T. Akrivos, George Vlahos, Zannis Voulgaris, E. Diacomanolis, P. Athanassiades, S. Mihalas

Article1999

Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study

Gerasimos Aravantinos, Dimitrios Bafaloukos, Meletios A Dimopoulos, C. Nikolaides, Pavlos Papakostas, Christos Kiamouris, K. Sikiotis, T. Rapsomaniki, George Fountzilas, D. Skarlos